In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: An 85-day multicenter trial

Chest

Volumn 105, Issue 5, 1994, Pages 1411-1419

  Bone, R ^a   Boyars, M ^a   Braun, S R ^a   Buist, A S ^a   Campbell, S ^a   Chick, T ^a   Cohen, B M ^a   Conway, W ^a   Cugell, D W ^a   DeGraff, A ^a   Friedman, M ^a   George, R B ^a   Gershwin, E ^a   Kram, J A ^a   Levin, D C ^a   Levine, B ^a   Petty, T L ^a   Rennard, S ^a   Repsher, L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; SALBUTAMOL SULFATE; STEROID; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADULT; AEROSOL; AGED; AREA UNDER THE CURVE; ARTICLE; BRONCHODILATING ACTIVITY; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0028318612     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.105.5.1411     Document Type: Article

References (27)

1. Gross NJ COPD: a disease of reversible air-flow obstruction Am Rev Respir Dis 133 1986 725 726
2. Anthonisen NR Wright EC IPPB Trial Group Bronchodilator response in chronic obstructive pulmonary disease Am Rev Respir Dis 133 1986 814 819
3. Gross NJ Korodin MS Anticholinergic, antimuscarinic bronchodilators Am Rev Respir Dis 129 1984 856 870
4. Braun SR Levy SF Grossman J Comparison of ipratropium bromide and albuterol in chronic obstructive pulmonary disease: a three-center study Am J Med 91 suppl 4A 1991 28 32S
5. Hughes JA Tobin MJ Bellamy D Hutchison DCS Effect of ipratropium bromide and fenoterol in pulmonary emphysema Thorax 37 1982 667 670
6. Gross NJ Ipratropium bromide N Engl J Med 319 1988 486 494
7. Casali L Grassi C Rampulla C Rossi A Clinical pharmacology of a combination of bronchodilators Int J Clin Pharmacol Biopharm 7 1979 277 280
8. Lees AW Allan GW Smith J Nebulised ipratropium bromide and salbutamol in chronic bronchitis Br J Clin Pract 3 1980 340 342
9. Leitch AG Hopkin JM Ellis DA Merchant S McHardy GJR The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis Thorax 33 1978 711 713
10. Petrie GR Palmer KNV Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma BMJ 1 1975 430 432
11. Lightbody IM Ingram CG Legge JS Johnston RN Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis Br J Dis Chest 72 1978 181 186
12. Easton PA Jadue C Dhingra S Anthonisen NR A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide) given by aerosol alone or in sequence N Engl J Med 315 1985 735 739
13. Lloberes P Ramis L Montserrat JM Serra J Campistol J Picado C Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease Eur Respir J 1 1988 536 539
14. Barros MJ Rees PJ Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction Respir Med 84 1990 371 375
15. 2-agonist and combination therapy on respiratory impedance in COPD Chest 101 1992 166 173
16. Marlin GE Studies of ipratropium bromide and fenoterol administered by metered-dose inhaler and aerosolized solution Respiration 50 suppl 2 1986 290 293
17. Serra C Giacopelli A Controlled clinical study of a long-term treatment of chronic obstructive lung disease using a combination of fenoterol and ipratropium bromide in aerosol form Respiration 50 suppl 2 1986 249 253
18. Morton O Response to Duovent of chronic reversible airways obstruction—a controlled trial in general practice Postgrad Med J 60 suppl 1 1984 32 35
19. LeDoux EJ Morris JF Temple WP Duncan C Standard and double dose ipratropium bromide and combined ipratropium bromide and inhaled metaproterenol in COPD Chest 95 1989 1013 1016
20. Morris JF Koski A Temple WP Claremont A Thoma DR Fifteen-year interval spirometric evaluation of the Oregon predictive equations Chest 93 1988 123 127
21. Vollmer VM Johnson LR Buist AS Relationship of response to a bronchodilator and decline in forced expiratory volume in one second in population studies Am Rev Respir Dis 132 1985 1186 1193
22. 1 in chronic bronchitis Aust N Z J Med 4 1974 339 354
23. Anthonison NR Wright EC Hodgkin JE Prognosis in chronic obstructive pulmonary disease Am Rev Respir Dis 133 1986 14 20
24. Anthonisen NR Wright EC IPPB Trial Group Response to inhaled bronchodilators in COPD Chest 5 sup 1 1987 36 39S
25. Postma DS De Vries K Koeter GH Sluiter HJ In Jependent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction Am Rev Respir Dis 134 1986 276 280
26. Phillips VJ The background to Duovent Postgrad Med J 60 suppl 1 1984 13 17
27. Ohrui T Yanai M Sekizawa K Marikawa M Sasaki H Takishima T Effective site of bronchodilation by beta-adrenergic and anticholinergic agents in patients with chronic obstructive pulmonary disease: direct measurement of intrabronchial pressure with a new catheter Am Rev Respir Dis 146 1992 88 91